Humana (NYSE:HUM) Issues FY24 Earnings Guidance

Humana (NYSE:HUM) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share guidance of at least $16.00 for the period, compared to the consensus earnings per share estimate of $16.17. Humana also updated its FY 2024 guidance to 16.000- EPS.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on HUM. Barclays upped their price target on shares of Humana from $250.00 to $253.00 and gave the stock an “equal weight” rating in a research report on Thursday. KeyCorp began coverage on shares of Humana in a research note on Friday, October 11th. They set a “sector weight” rating on the stock. Royal Bank of Canada dropped their price objective on shares of Humana from $400.00 to $265.00 and set an “outperform” rating for the company in a research report on Tuesday, October 8th. Leerink Partnrs lowered Humana from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on Humana from $349.00 to $250.00 and set a “hold” rating for the company in a research report on Thursday, October 3rd. One research analyst has rated the stock with a sell rating, nineteen have assigned a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $315.48.

Humana Stock Performance

Shares of HUM stock traded up $2.88 during trading on Friday, reaching $260.71. 1,424,246 shares of the company’s stock were exchanged, compared to its average volume of 1,856,202. Humana has a twelve month low of $213.31 and a twelve month high of $527.18. The firm’s fifty day moving average price is $297.06 and its 200-day moving average price is $334.38. The company has a quick ratio of 1.66, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $31.39 billion, a PE ratio of 23.09, a PEG ratio of 2.07 and a beta of 0.50.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, beating the consensus estimate of $3.48 by $0.68. The company had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. As a group, sell-side analysts anticipate that Humana will post 16.06 EPS for the current year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.36%. The ex-dividend date is Tuesday, December 31st. Humana’s dividend payout ratio is presently 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.